Answers are grounded in this paper and cite their sources.
An improved, scalable synthesis of the CXCR4 antagonist GSK812397 is described. This new route was recently scaled up in 50 L fixed equipment to afford 1.2 kg of drug substance in five steps with an overall yield of 20% and >99% chemical and enantiomeric purity.
No takes yet. Share an insight, caveat, or question.
Boggs et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: